Inhibition of Melanogenesis by the Antidiabetic Metformin-Reference-Cited by-同舟云学术

Inhibition of Melanogenesis by the Antidiabetic Metformin

Published:2014-10 Issue:10 Volume:134 Page:2589-2597
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Lehraiki Abdelali,Abbe Patricia,Cerezo Michael,Rouaud Florian,Regazzetti Claire,Chignon-Sicard Bérengère,Passeron Thierry,Bertolotto Corine,Ballotti Robert,Rocchi Stéphane

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference23 articles.

1. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation;Ao;Exp Cell Res,1998

2. p38 regulates pigmentation via proteasomal degradation of tyrosinase;Bellei;J Biol Chem,2010

3. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?;Ben Sahra;Mol Cancer Ther,2010

4. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product;Bertolotto;J Cell Biol,1996

5. A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF;Borgdorff;Oncogene,2014

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatment of hyperpigmentation;Dermatologie pro praxi;2024-06-03

2. Does Systemic Metformin Have a Role in Treating Melasma?;Dermatologic Surgery;2024-02-28

3. (2-Methylbutyryl)shikonin Naturally Occurring Shikonin Derivative Ameliorates the α-MSH-Induced Melanogenesis via ERK1/2 and p38 MAP Kinase-Mediated Down-Regulation of the MITF Transcription Factor;Chemical Research in Toxicology;2024-01-25

4. Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-12-13

5. Synthesis and Characterization of Cosmetic Grade Ionic Liquids and Their Application as Skin Whitening Agents;Journal of Pharmaceutical Innovation;2023-11-14